RxDoctor Payments Data

Mai Luu

Family Medicine · Albuquerque, NMNPI 1306108402

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $606 and has fallen 95.2% since, to $29 in 2025.

$1,447in general payments, 2019–2025

Across 83 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$186
  • Amgen$144
  • Novo Nordisk$135
  • AbbVie$134
  • Amarin Pharma, Inc.$119
  • Pfizer$102
  • plus $627 from 18 others

What the payments were for

  • Food & beverage$1,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,447 in reported general payments places this provider in the 85th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico →

Other family medicine in Albuquerque

See the full list for New Mexico →

Where these figures come from

Is this you, or does something look wrong? →